Back to funds
View filing
Frazier Life Sciences Management, L.P.
hedge fundUpdated 28 days agoManaged by Frazier Life Sciences Management, L.P. • Latest filing Q2 2026
Portfolio value
$4.6B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
43.4%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $1.4B |
| Q2 2023 | $1.7B |
| Q3 2023 | $1.5B |
| Q4 2023 | $1.9B |
| Q1 2024 | $2.4B |
| Q2 2024 | $2.1B |
| Q3 2024 | $2.5B |
| Q4 2024 | $2.4B |
| Q1 2025 | $2.2B |
| Q2 2025 | $2.5B |
| Q3 2025 | $3.3B |
| Q4 2025 | $3.7B |
| Q1 2026 | $3.9B |
| Q2 2026 | $4.6B |
Top holdings
41 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | M MIRM MIRUM PHARMACEUTICALS INC | $899.1M | 7.68M | 19.58% | — |
| 2 | N NAMSW NEWAMSTERDAM PHARMA COMPANY | $613M | 18.09M | 13.35% | — |
| 3 | E EQR ERASCA INC | $457.5M | 24.98M | 9.96% | — |
| 4 | M MBX MBX BIOSCIENCES INC | $367.2M | 6.65M | 8.00% | — |
| 5 | A ARQT ARCUTIS BIOTHERAPEUTICS INC | $258.9M | 9.87M | 5.64% | — |
| 6 | T TRVI TREVI THERAPEUTICS INC | $185.4M | 9.94M | 4.04% | — |
| 7 | K KRYS KRYSTAL BIOTECH INC | $178.9M | 481.3K | 3.90% | — |
| 8 | M MAZE MAZE THERAPEUTICS INC | $150.2M | 5.03M | 3.27% | — |
| 9 | P PHAT PHATHOM PHARMACEUTICALS INC | $135.3M | 12.47M | 2.95% | — |
| 10 | P PVLA PALVELLA THERAPEUTICS INC NE | $134.8M | 882.4K | 2.94% | — |
| 11 | B BBIO BRIDGEBIO PHARMA INC | $115.3M | 1.55M | 2.51% | — |
| 12 | I IRON DISC MEDICINE INC | $99.1M | 1.35M | 2.16% | — |
| 13 | C CYTK CYTOKINETICS INC | $98.8M | 1.16M | 2.15% | — |
| 14 | D DYN DYNE THERAPEUTICS INC | $70M | 3.15M | 1.52% | — |
| 15 | A ASND ASCENDIS PHARMA A/S | $60.1M | 225.2K | 1.31% | — |
| 16 | S SVRA SAVARA INC | $59.9M | 9.72M | 1.30% | — |
| 17 | P PBLS PARABILIS MEDICINES INC | $52.6M | 1.92M | 1.14% | — |
| 18 | A AURA AURA BIOSCIENCES INC | $50.4M | 7.10M | 1.10% | — |
| 19 | A ACHV ACHIEVE LIFE SCIENCE INC | $49.7M | 7.61M | 1.08% | — |
| 20 | V VOR VOR BIOPHARMA INC | $46.8M | 2.54M | 1.02% | — |